Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Other financing activities (2020 - 2025)

Exagen (XGN) has disclosed Other financing activities for 2 consecutive years, with $199000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other financing activities changed N/A year-over-year to $199000.0, compared with a TTM value of $869000.0 through Dec 2025, changed N/A, and an annual FY2025 reading of $869000.0, changed N/A over the prior year.
  • Other financing activities was $199000.0 for Q3 2025 at Exagen, down from $605000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $4.2 million in Q1 2021 and bottomed at -$4.4 million in Q4 2021.